Biotech Co. Gets Investor Suit Over Failed COVID Test Tossed

By Katryna Perera · December 12, 2022, 6:25 PM EST

A biotech company that was sued by investors over issues with its COVID-19 test rollout convinced a California federal judge to toss the suit after arguing that none of the statements identified...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

IN RE Talis Biomedical Securities Litigation

Case Number

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

January 07, 2022

Recent Articles By Katryna

July 01, 2024
Delta Dental Wants Antitrust Claims Standard Decided Now
June 06, 2024
White Collar Boutique Sued By Ex-Client Over Representation
June 04, 2024
Biotech RenovaCare Can't Beat Investors' Stock Promo Suit
June 03, 2024
Humana Hit With Investor Suit Over Post-COVID Costs
May 30, 2024
Veradigm Execs Sued Over Company's Nasdaq Delisting
May 20, 2024
iRhythm Brass Face Suit Over FDA's Heart Monitor Inquiry
May 02, 2024
Masimo Hit With Derivative Suit Over Audio Co. Acquisition
May 01, 2024
Insulin Pump Maker Wins Toss of Investor Suit For Now
April 30, 2024
Vaxart Investors Want Sanctions Over Deleted Texts
April 08, 2024
Walmart Beats Investor Suit Over Opioid Probe Disclosures